Tue, 8 July 2014
Please join the 36th Annual Winn Feline Foundation Symposium in New Orleans on July 26, 2014. This audio portion features the Symposium introduction with nationally known radio personality, Steve Dale, as he talks about the Winn Feline Foundation and introduces Beth Licitra. Beth Licitra is a combined DVM and PhD candidate at Cornell University and is involved in research through the Whittaker Laboratory at the University.
Beth Licitra’s presentation will cover the discovery where “Pathogenesis of feline coronavirus is linked to mutation of a critical viral activation site”. Research in the Whittaker Laboratory focuses on investigations into the initial steps of virus infection. This includes binding of the virus to its host receptor, activation of viral attachment proteins by host proteases, and fusion of viral and host cell membranes. Their work also looks at human and avian influenza viruses as well as coronaviruses such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). The talk summarizes their findings on the correlation between mutations in the FCoV spike protein and the development of FIP. It also highlights their current work on the role of host cell proteases in the progression of this fatal disease. The Whittaker Laboratory's research has uncovered a molecular basis for FIP that has potential to lead to developments in diagnostics, prevention, and treatment.
Direct download: Winn_36th_Annual_Symposium-Intro_and_Beth_Licitra_on_FIP.mp3
Category:Feline Health and Research -- posted at: 9:00am PDT
Comments[0]
|
Tue, 8 July 2014
Please join the 36th Annual Winn Feline Foundation Symposium in New Orleans on July 26, 2014. This audio portion features nationally known radio personality, Steve Dale, as he introduces Dr. Philip Fox, DVM, DACVIM, DECVIM, and ACVECC Vincent Astor Chair in Comparative Medicine, Caspary Institute, Animal Medical Center in New York City.
Dr. Philip Fox presents on “NEW perspectives on survival: Comparison of healthy cats and cats with hypertrophic cardiomyopathy- A Global Study”. This multinational study involved some 60 investigators across 20 countries. The presentation will review the current relevant knowledge of feline hypertrophic cardiomyopathy with special focus on clinically relevant findings. In addition, for the first time, new data will clarify incidence of morbidities and mortality in cats with HCM including CHF and ATE, as well as in normal cats. Clinical risk factors for heart disease and cardiac death will also be included.
Direct download: Winn_36th_Annual_Symposium_-_Dr_Philip_Fox_on_HCM_QandA.mp3
Category:Feline Health and Research -- posted at: 9:00am PDT
Comments[0]
|